TradingHolo

The whole market. One view. Market data from our own platform. Not investment advice. Prices in listing currency with AED alongside; market cap in USD. Live = streaming now; Delayed 15 min where the exchange requires it; At close = last official close.

News Calendar Economy IPOs ETFs Account

⌂Home ◈Markets ▦Screener 📈Tools ◎Portfolio

Skip to content

DFM General5,842.87−0.15%FTSE ADX9,789.92+0.07%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100166,034.17+0.04%DFM:EMIRATESNBDAED 31.50+0.00%ADX:IHCAED 352.80+0.23%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 299.55+0.03%Gold$4,129.46−0.27%Brent$109.91+0.63%BTC$81,641.10−0.25%ETH$2,392.58−0.52%DFM General5,842.87−0.15%FTSE ADX9,789.92+0.07%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,690.73+0.41%Nasdaq 10029,529.34+1.17%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100166,034.17+0.04%DFM:EMIRATESNBDAED 31.50+0.00%ADX:IHCAED 352.80+0.23%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$217.09+1.38%NYSE:TSM$420.22+1.84%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 299.55+0.03%Gold$4,129.46−0.27%Brent$109.91+0.63%BTC$81,641.10−0.25%ETH$2,392.58−0.52%

Stock markets

🇦🇪UAEDFM · ADX · DFM GeneralOpen 🇸🇦Saudi ArabiaTadawul · TASIClosed 🇶🇦QatarQSE · QE GeneralClosed 🇺🇸United StatesNasdaq · NYSE · S&P 500Closed 🇮🇳IndiaNSE · BSE · Nifty 50Closed 🇵🇰PakistanPSX · KSE-100Open

Other assets

₿CryptoRanked by volume · 24/7 🥇Gold, FX & economyDubai gold, AED crosses, rates ◫ETFsIndex, sector and gold funds

Explore

▦Market mapEvery market as a heatmap 📅Calendar & IPOsEarnings, dividends, listings, releases ⌁Options flow · Ownership · PoliticsUS filings and tapes

⚲Stock screenerAll six markets, one row per company ★Ready-made screensStarting points with a point of view 📁My saved screensSaved rules with alerts on new matches ⇄CompareUp to five, side by side

📈ChartingDrawings, indicators, replay ▶Strategy MakerWrite a rule, test it on history ⇄CompareSide by side 🔔AlertsPrice, earnings, screens, strategies

⌕

Sign in Create account👤

Actuate Therapeutics Inc · Overview · TradingHolo

Markets › United States › NAS › ACTU

A

Actuate Therapeutics Inc

NAS:ACTUHealthcarenasdaq_composite

$0.5990−0.99%At closeAt close · Tue 20 Oct · ≈ AED 2.20 · Market cap $14.38M · Next earnings Thu 12 Nov

🔔 Alert▶ Test a strategy

Overview Chart Financials Valuation Forecasts Dividends Ownership Options Shorts News Profile

1D

−1.0%

1M

−39.0%

3M

−55.6%

6M

−77.1%

1Y

−92.3%

Why it's moving today

No company news in the last day; the move tracks its market and sector.

ACTU −0.99% today

✦ This week in three lines

No written digest yet for ACTU. The figures on this page are the source when one is written.

Financials

USD millions · annual3Y CAGR —

Valuation

P/E vs sector−0.6× vs −1.7×

Price / Book vs sector1.8× vs 2.0×

Price / Sales vs sector—

Price / Free cash flow vs sector−0.7× vs −1.6×

Forecasts

4 buy0 hold0 sell4 analysts

Average target$0.0000 −100.0%

Analysts0

EPS surprises, last 83 beats

Dividends

Yield0.0%

Annual payout—

Payout ratio0.0%

Next ex-date—

Years of growth—

Latest news

All ACTU news →

DOActuate Therapeutics' Stock Tumble on Plan to Sell 50M Shares

Dow Jones Newswires · 13 d ago

DOActuate Therapeutics to Issue 3.7M Warrants to Bios Partners and Kairos Venture Investments in Connection With Agreements Not to Sell Shares for Two Years After Stock Sale Closes

Dow Jones Newswires · 13 d ago

DOActuate Therapeutics Files to Sell 50M Shrs

Dow Jones Newswires · 13 d ago

Key facts

At close · Tue 20 Oct

Market cap (USD)$14.38M

P/E−0.6×

Dividend yield0.0%

52-week range$0.4100 – $8.01

Avg volume (20d)404,359

Shares outstanding24,014,202

Beta0.78

Short interest13.0% of float

Next earningsThu 12 Nov

Radar Score

24

Value37

Quality8

Momentum8

Income45

Peer percentile within United States Healthcare0–100 · null when more than one input is missing

About

Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating treatments for various cancers. Its primary drug candidate is Elraglusib Injection, an innovative glycogen synthase kinase-3 (GSK-3) inhibitor designed to combat metastatic pancreatic ductal adenocarcinoma.…

SectorHealthcare

IndustryNormal

ExchangeNAS

Peers

LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE

56.6×−1.33%

JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE

22.8×−0.69%

ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE

118.2×−0.96%

UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE

30.3×+1.36%